Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buphenyl in Maple Syrup Urine Disease
NCT01529060Phase 3Completed
- Start
- Feb 2013
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
A Phase 3 trial of sodium phenylbutyrate in maple syrup urine disease (MSUD). Started Feb 2013; status: completed.
02
Drugs
sodium phenylbutyrate
03
Conditions
maple syrup urine disease (MSUD)
Beyond the preview
Go deeper on NCT01529060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529060.